Related Experiment Video
Updated: Aug 25, 2026
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with
Masahiko Tomiyama1, Tamaki Kimura, Tetsuya Maeda
1Third Department of Medicine, Hirosaki University School of Medicine, Hirosaki 036-8216, Japan. tomiyama@cc.hirosaki-u.ac.jp
Abstract:
To determine whether the adenosine A2A receptor might play a role in L-DOPA-induced dyskinesia in Parkinson's disease, we analyzed changes in the expression of A2A receptor mRNA in response to intermittent treatment with L-DOPA in rats with dopaminergic denervation by 6-hydroxydopamine (OHDA) infusion into the medial forebrain bundle. Intermittent treatment with L-DOPA increased A2A receptor mRNA levels in the dopamine-depleted striatum of 6-OHDA-lesioned rats exhibiting behavioral sensitization to L-DOPA. These results suggest that A2A receptor activation is associated with the development of motor complications induced by L-DOPA treatment.
Insights
Adenosine A2A receptor activation is linked to L-DOPA-induced dyskinesia in Parkinson's disease. This study found increased A2A receptor mRNA in rats treated with L-DOPA, suggesting a role in motor complications.
Area of Science:
- Neuroscience
- Pharmacology
- Parkinson's Disease Research
Background:
- Parkinson's disease (PD) is characterized by motor deficits due to dopamine loss.
- L-DOPA is a primary treatment, but motor complications like dyskinesia develop over time.
- The role of adenosine A2A receptors in L-DOPA-induced dyskinesia (LID) is not fully understood.
Purpose of the Study:
- To investigate the involvement of adenosine A2A receptors in the development of L-DOPA-induced dyskinesia.
- To analyze changes in A2A receptor mRNA expression following intermittent L-DOPA treatment in a rat model of PD.
Main Methods:
- Utilized a 6-hydroxydopamine (OHDA) rat model to induce dopaminergic denervation.
- Administered intermittent L-DOPA treatment to assess behavioral changes and receptor expression.
- Quantified A2A receptor mRNA levels in the striatum using molecular techniques.
Main Results:
- Intermittent L-DOPA treatment led to increased A2A receptor mRNA expression in the dopamine-depleted striatum.
- These increases were observed in rats exhibiting behavioral sensitization to L-DOPA.
- A correlation was found between L-DOPA treatment, A2A receptor mRNA levels, and motor complications.
Conclusions:
- Adenosine A2A receptor activation is associated with the development of L-DOPA-induced dyskinesia in Parkinson's disease.
- Targeting A2A receptors may offer a therapeutic strategy to mitigate motor complications in PD patients.
- Further research is warranted to explore the precise mechanisms linking A2A receptors and LID.
